182 related articles for article (PubMed ID: 28398958)
1. New-onset diabetes in HIV-treated adults: predictors, long-term renal and cardiovascular outcomes.
Putcharoen O; Wattanachanya L; Sophonphan J; Siwamogsatham S; Sapsirisavat V; Gatechompol S; Phonphithak S; Kerr SJ; Chattranukulchai P; Avihingsanon Y; Ruxrungtham K; Avihingsanon A;
AIDS; 2017 Jul; 31(11):1535-1543. PubMed ID: 28398958
[TBL] [Abstract][Full Text] [Related]
2. Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment.
Capeau J; Bouteloup V; Katlama C; Bastard JP; Guiyedi V; Salmon-Ceron D; Protopopescu C; Leport C; Raffi F; Chêne G;
AIDS; 2012 Jan; 26(3):303-14. PubMed ID: 22089377
[TBL] [Abstract][Full Text] [Related]
3. Effect of Tenofovir Disoproxil Fumarate on Incidence of Chronic Kidney Disease and Rate of Estimated Glomerular Filtration Rate Decrement in HIV-1-Infected Treatment-Naïve Asian Patients: Results from 12-Year Observational Cohort.
Suzuki S; Nishijima T; Kawasaki Y; Kurosawa T; Mutoh Y; Kikuchi Y; Gatanaga H; Oka S
AIDS Patient Care STDS; 2017 Mar; 31(3):105-112. PubMed ID: 28282247
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting.
Kaboré NF; Poda A; Zoungrana J; Da O; Ciaffi L; Semdé A; Yaméogo I; Sawadogo AB; Delaporte E; Meda N; Limou S; Cournil A
BMC Nephrol; 2019 May; 20(1):155. PubMed ID: 31064340
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.
Rossi C; Raboud J; Walmsley S; Cooper C; Antoniou T; Burchell AN; Hull M; Chia J; Hogg RS; Moodie EE; Klein MB;
BMC Infect Dis; 2017 Apr; 17(1):246. PubMed ID: 28376824
[TBL] [Abstract][Full Text] [Related]
6. Incidence of lipodystrophy and metabolic disorders in patients starting non-nucleoside reverse transcriptase inhibitors in Benin.
Zannou DM; Denoeud L; Lacombe K; Amoussou-Guenou D; Bashi J; Akakpo J; Gougounon A; Akondé A; Adé G; Houngbé F; Girard PM
Antivir Ther; 2009; 14(3):371-80. PubMed ID: 19474471
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults.
Jantarapakde J; Phanuphak N; Chaturawit C; Pengnonyang S; Mathajittiphan P; Takamtha P; Dungjun N; Pinyakorn S; Pima W; Prasithsirikul W; Phanuphak P
AIDS Patient Care STDS; 2014 Jul; 28(7):331-40. PubMed ID: 24914459
[TBL] [Abstract][Full Text] [Related]
8. Impact of dietary fiber intake on glycemic control, cardiovascular risk factors and chronic kidney disease in Japanese patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry.
Fujii H; Iwase M; Ohkuma T; Ogata-Kaizu S; Ide H; Kikuchi Y; Idewaki Y; Joudai T; Hirakawa Y; Uchida K; Sasaki S; Nakamura U; Kitazono T
Nutr J; 2013 Dec; 12():159. PubMed ID: 24330576
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance in people living with HIV is associated with exposure to thymidine analogues and/or didanosine and prior immunodeficiency.
Høgh J; Hove-Skovsgaard M; Gelpi M; Jensen AMR; Gerstoft J; Benfield T; Storgaard H; Nielsen SD
BMC Infect Dis; 2022 May; 22(1):503. PubMed ID: 35643429
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral therapy and the human immunodeficiency virus--improved survival but at what cost?
Bradbury RA; Samaras K
Diabetes Obes Metab; 2008 Jun; 10(6):441-50. PubMed ID: 17825081
[TBL] [Abstract][Full Text] [Related]
11. Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial.
Bussmann H; Wester CW; Thomas A; Novitsky V; Okezie R; Muzenda T; Gaolathe T; Ndwapi N; Mawoko N; Widenfelt E; Moyo S; Musonda R; Mine M; Makhema J; Moffat H; Essex M; Degruttola V; Marlink RG
J Acquir Immune Defic Syndr; 2009 May; 51(1):37-46. PubMed ID: 19282782
[TBL] [Abstract][Full Text] [Related]
12. The role of nucleoside reverse transcriptase inhibitors usage in the incidence of hyperlactatemia and lactic acidosis in HIV/AIDS patients.
Dragovic G; Jevtovic D
Biomed Pharmacother; 2012 Jun; 66(4):308-11. PubMed ID: 22658063
[TBL] [Abstract][Full Text] [Related]
13. Use of the waist-to-height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE-ON study.
Rådholm K; Chalmers J; Ohkuma T; Peters S; Poulter N; Hamet P; Harrap S; Woodward M
Diabetes Obes Metab; 2018 Aug; 20(8):1903-1910. PubMed ID: 29603537
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral therapy modifies the genetic effect of known type 2 diabetes-associated risk variants in HIV-infected women.
Frasco MA; Karim R; Van Den Berg D; Watanabe RM; Anastos K; Cohen M; Gange SJ; Gustafson DR; Liu C; Tien PC; Mack WJ; Pearce CL
AIDS; 2014 Jul; 28(12):1815-23. PubMed ID: 24932614
[TBL] [Abstract][Full Text] [Related]
15. Incidence of diabetes mellitus in a population-based cohort of HIV-infected and non-HIV-infected persons: the impact of clinical and therapeutic factors over time.
Tripathi A; Liese AD; Jerrell JM; Zhang J; Rizvi AA; Albrecht H; Duffus WA
Diabet Med; 2014 Oct; 31(10):1185-93. PubMed ID: 24673640
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.
De Wit S; Sabin CA; Weber R; Worm SW; Reiss P; Cazanave C; El-Sadr W; Monforte Ad; Fontas E; Law MG; Friis-Møller N; Phillips A;
Diabetes Care; 2008 Jun; 31(6):1224-9. PubMed ID: 18268071
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study.
Ledergerber B; Furrer H; Rickenbach M; Lehmann R; Elzi L; Hirschel B; Cavassini M; Bernasconi E; Schmid P; Egger M; Weber R;
Clin Infect Dis; 2007 Jul; 45(1):111-9. PubMed ID: 17554711
[TBL] [Abstract][Full Text] [Related]
18. Nucleoside reverse transcriptase inhibitor usage and the incidence of peripheral neuropathy in HIV/AIDS patients.
Dragovic G; Jevtovic D
Antivir Chem Chemother; 2003 Sep; 14(5):281-4. PubMed ID: 14694991
[TBL] [Abstract][Full Text] [Related]
19. [Abnormal body fat distribution and type of antiretroviral therapy as predictors of cardiovascular disease risk in HIV-infected patients].
Ena J; Benito C; Llácer P; Pasquau F; Amador C
Med Clin (Barc); 2004 May; 122(19):721-6. PubMed ID: 15171905
[TBL] [Abstract][Full Text] [Related]
20. New-Onset Diabetes and Antiretroviral Treatments in HIV-Infected Adults in Thailand.
Riyaten P; Salvadori N; Traisathit P; Ngo-Giang-Huong N; Cressey TR; Leenasirimakul P; Techapornroong M; Bowonwatanuwong C; Kantipong P; Nilmanat A; Yutthakasemsunt N; Chutanunta A; Thongpaen S; Klinbuayaem V; Decker L; Le Cœur S; Lallemant M; Capeau J; Mary JY; Jourdain G
J Acquir Immune Defic Syndr; 2015 Aug; 69(4):453-9. PubMed ID: 25886928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
